Carl Gordon, Director at Intellia Therapeutics, holds ― shares in Intellia Therapeutics (Ticker: NTLA), holds 3.81M shares in MBX Biosciences, Inc. (Ticker: MBX), holds 119.52K shares in Keros Therapeutics (Ticker: KROS). Most recently, Carl Gordon ― shares of Intellia Therapeutics on ― for an estimated value of ―.
Carl Gordon latest transaction was an Uninformative Buy of ―.
What was Carl Gordon's most profitable transaction?
Carl Gordon’s most profitable transaction was an Informative Buy of KROS stock on April 13, 2020. The return on the trade was 175.70%.
What is Carl Gordon's role in Intellia Therapeutics?
Carl Gordon's role in Intellia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.